Le Lézard
Classified in: Health
Subject: FDA

Maxx Orthopedics Announces US FDA Approval of Freedom® Ultra-Congruent Liner Option Ahead of American Academy of Orthopaedic Surgeons (AAOS) Meeting

NORRISTOWN, Pa., March 7, 2019 /PRNewswire-PRWeb/ -- Maxx Orthopedics, Inc. a subsidiary of Maxx Medical, Pvt. Ltd., a rapidly expanding global orthopedics device company, today announced that it has received US FDA clearance for its Freedom® Ultra-Congruent liner, the latest addition to its Freedom Knee® System.

The Freedom® Ultra-Congruent Liner (UC) was developed with the desire to achieve a higher level of constraint than typically achieved in a traditional cruciate-retaining (CR) knee design. The UC tibial liner includes a deep anterior patellar cut-out to allow for tendon clearance, a prominent anterior lip that aids in prevention of anterior subluxation of the femur, and a prominent posterior lip that assists in resisting posterior translation of the femur. Providing patients with more precise balance and stability, the thickness offerings for the Freedom® Ultra-Congruent Liner will be 1mm increments throughout the size range.

"We are thrilled to add the UC liner offering to our Freedom® Knee System. In addition to the unique design of the Ultra-Congruent liner, we are also introducing new liner thicknesses to help our customers better match the Freedom Knee to the needs of the individual patient. This is an evolutionary step towards our goal of creating and providing solutions that best fit our patients' needs so they, along with our medical professionals, continue to have the best possible outcomes." said Ashesh Shah, CEO, Maxx Medical.

Launched in 2009, The Freedom Knee® System is a total knee replacement system specifically engineered for high flexion, bone conservation and advanced component size and fit capabilities. Maxx will be displaying The Freedom® Ultra-Congruent Liner at AAOS Annual Meeting, March 13-15, in Las Vegas, NV (Booth #2063). For additional information, please visit http://www.maxxortho.com.

About Maxx Medical
Maxx Medical Pvt. Ltd. ("Maxx Medical") develops and markets innovative orthopedic medical devices on an international scale. The company is focused on providing state-of-the-art implants and related solutions that best restore patient mobility while accommodating lifestyle, anatomical and economic needs. Maxx Medical is the parent company of Maxx Orthopedics, Inc., the manufacturer of the Freedom Knee® System and Libertas® Total Hip System.


SOURCE Maxx Orthopedics

These press releases may also interest you

at 14:00
As two leading organizations dedicated to quality and efficiency in healthcare delivery, Simione Healthcare Consultants, LLC, (Simone) and Home Health Solutions, LLC, (HHS) announced a new strategic partnership today that will combine their...

at 14:00
LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today announced that Donna L. LaVoie, President, CEO and Founder of LHS, has been named to the PharmaVOICE...

at 13:46
Leading fitness franchise concept TruFusion announced today the debut of its new prototype, an innovative studio model with a significantly smaller footprint than the brand's flagship design. TruFusion invested in designing a new prototype to expand...

at 13:45
Discovery Senior Living's SHINE® Memory Care program has received a national Certificate of Recognition from the Alzheimer's Association, the country's leading, voluntary health organization dedicated to Alzheimer's care and research. The distinction...

at 13:33
As part of its broader focus to improve the long-term sustainability of high quality and affordable health care, Blue Cross and Blue Shield of Minnesota (Blue Cross) today announced that supportive care services from Livio Health will be expanded to...

at 13:32
Whether children have ongoing sleep problems from birth through childhood or do not develop sleep problems until they begin school, a new study by researchers at Children's Hospital of Philadelphia (CHOP) has found that sleep disturbances at any age...

News published on 7 march 2019 at 14:00 and distributed by: